Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

DIGITAL, Canada's Global Innovation Cluster for digital technologies, is celebrating its ongoing impact and investment in ...

The Dovetail Certified Service Provider program sets stringent standards of proficiency and data quality that service labs ...

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that gets saliva samples sequenced and then compares the DNA results to extensive data linking health issues ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...